Citation only
via OpenAlex
MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM
Н. Г. Плехова, Новикова Полина Андреевна, Shumatov V.B.
Bulletin Biomedicine and sociology · 2024
Stem-cell exhaustion
Chronic inflammation
Stem-cell therapy
Partial reprogramming (OSK)
Cell culture / in vitro
Review
Abstract
Mesenchymal stem/stromal cells (MSCs) and fibroblasts are present in normal tissues to maintain tissue homeostasis and share a number of common features such as spindle-shaped morphology, localization in connective tissue, and multipotency. During inflammation, fibroblasts and MSCs non-specifically respond to injury via two mechanisms of action: immunomodulation and regeneration. Upon tissue injury, MSCs are activated, proliferate, and differentiate. With age and, in particular, in degenerative diseases of the musculoskeletal system (diseases of the muscles, joints and bones), the regenerative capacity of MSCs is lost or redirected to the production of other non-functional cell types such as adipocytes and fibroblasts, which provide much of the structural framework of almost all tissue types. By performing an immunosuppressive role, MSCs and fibroblasts contribute to the normal resolution of inflammation, which is a prerequisite for successful tissue repair. The aim of the review is to provide an understanding of the common and opposite properties of MSCs and FB from the standpoint of age-related changes in the musculoskeletal system in order to develop approaches to their complementary assistance for successful tissue regeneration. The key features of aging MSC and fibroblast are presented, and it is indicated that additional studies are needed on the cellular mechanisms that together generate dysfunctions of individual niches of terminal differentiated cells during aging. The currently existing technologies of cell therapy for the musculoskeletal system diseases involving MSCs and fibroblasts are presented.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.26787/nydha-2618-8783-2024-9-3-33-43
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Плехова, �.�., Андреевна, �.�., & V.B., S. (2024). MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM. <em>Bulletin Biomedicine and sociology</em>. https://doi.org/10.26787/nydha-2618-8783-2024-9-3-33-43
Vancouver
Плехова ��, Андреевна ��, V.B. S. MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM. Bulletin Biomedicine and sociology. 2024. doi:10.26787/nydha-2618-8783-2024-9-3-33-43.
BibTeX
@article{2024MESENC,
title = {MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM},
author = {Н. Г. Плехова and Новикова Полина Андреевна and Shumatov V.B.},
journal = {Bulletin Biomedicine and sociology},
year = {2024},
doi = {10.26787/nydha-2618-8783-2024-9-3-33-43},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochemistry 2021
Open access · CC-BY
Mesenchymal Stem/Stromal Cells and Fibroblasts: Their Roles in Tissue Injury and Regeneration, and Age-Related Degeneration
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Stem cell-based therapy for human diseases
Stem cell reviews and reports 2026
Citation only
Stem Cells in Aging and Anti-Aging.
International Journal of Molecular Sciences 2019
Open access · CC-BY
Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration
Frontiers in Bioengineering and Biotechnology 2023
Open access · CC-BY